|
Protocol ID |
Official Title |
Principal Investigator |
Lead CRC |
Disease Site |
Phase |
|
A011202 ClinicalTrials.gov # |
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy |
Dr. Sharad Ghamande |
Breast |
III |
|
|
MK7339-009 ClinicalTrials.gov # |
An Open-label, Randomized, Phase 2/3 Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction of Clinical Benefit With First-line Chemotherapy Plus Pembrolizumab in Participants With Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (TNBC) |
Dr. Allen Krutchik |
Breast |
II/III |
|
|
NRG-BR003 ClinicalTrials.gov # |
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer |
Dr. Sharad Ghamande |
Breast |
III |
|
|
SGNTUC-016 ClinicalTrials.gov # |
Randomized, Double-Blind, Phase 3 Study of Tucatinib or Placebo in Combination with Ado-Trastuzumab Emtansine (T DM1) for Subjects with Unresectable Locally-Advanced or Metastatic HER2+ Breast Cancer |
Dr. Allen Krutchik |
Breast |
III |
|
|
WCI4472-18 ClinicalTrials.gov # |
A Phase II Multi-institutional Study of Concurrent Radiotherapy, Palbociclib, and Hormone Therapy for Treatment of Bone Metastasis in Breast Cancer Patients |
Dr. Catherine Ferguson |
Breast |
II |
